Her2-overexpression
<p>Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis</p>
... of HER2-enriched breast cancers primarily depends on the biological characteristics of the disease rather than the content of surgical ...the HER2 subtype. 21 In the BCT cohort, HER2 subtype of ...
12
Inhibition of phosphatidylcholine specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
... total HER2 expression on the membrane (Figure 7a, left panels), in agreement with a previous report ...of HER2 was noted at the membrane level at 5 hours, which lasted for at least 48 hours (Figure 7, right ...
16
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
... Data from published studies comparing these different analytical methods are conflicting. At least nine publica- tions compared DNA copy number measured by PCR with in situ methods, IHC/FISH-CISH. In the past dif- ferent ...
12
Original Article The correlation of PTPN4 expression with prognosis in breast cancer
... (HER2) overexpression are susceptible to trastuzumab, but triple nega- tive breast cancer patients who lack targeted biomarkers have the poorest outcomes ...
9
... predicted the overexpression of HER2 among locally advanced gastric cancer patients. Therefore, this finding is consistent with the known feature of serum CA724 and suggests serum CA724 as a preferable ...
11
<p>Personalized medicine in breast cancer: pharmacogenomics approaches</p>
... of HER2 and poor internalization of the HER2-drug, which is associated with insuf fi cient intracel- lular expression of DM1, represent the primary mechan- isms to drug ...of HER2 ...
15
HER2 regulates HIF 2α and drives an increased hypoxic response in breast cancer
... when HER2 is ...The HER2-mediated in- crease in the expression of these genes in hypoxia suggests that the increased aggressiveness of HER2-positive breast cancer may in part be due to the increased ...
18
Original Article Clinicopathological characteristics of primary squamous cell carcinoma of breast
... with HER2 overexpression and/ or HER2 gene amplification, and positive for at least two basal markers (basal-HER2 pheno- type), a worse prognosis was noted in this group of patients comparing ...
9
Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery
... a HER2 negative cell line that should not generate HER2 specific signal; however, when targeted probe alone was assessed, some nonspecific uptake of HER2 was seen (AUC = ...0.50). HER2 ...
13
Original Article HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients
... the HER2 status of 171 UUTUC patients with nephroure- ...any HER2 study. All 171 cases were analyzed for both HER2 overexpression using immunohistochemistry and HER2 gene amplification ...
10
Original Article Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues
... have HER2 overexpression, and they usually show poor recovery ...of HER2 expression, immuno- histochemistry (IHC) and fluorescence in situ hybridization (FISH) methods are conventionally ...detect ...
8
HER2 STATUS BREAST CANCER IN A POPULATION OF WESTERN ALGERIA
... The HER2 gene is an oncogene encoding a human growth factor and amplified in breast ...cancer. Overexpression of the corresponding protein is usually the result of HER2 gene amplification secondary ...
6
Original Article Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters
... investigated HER2 expres- sion in upper urinary tract urothelial carcinoma ...evaluated HER2 overexpression by ...document HER2 expression in 20 cases of urothelial carcinoma of the renal ...
7
Trastuzumab, an appropriate first line single agent therapy for HER2 overexpressing metastatic breast cancer
... of HER2 gene amplification in ductal carcinoma in situ (DCIS) of the breast is the same as or higher than that in metastatic breast cancer ...that HER2 overexpression occurs years before the onset of ...
5
The Effect Of Emphasizing Key Vocabulary On Student Achievement With English Learners
... not HER2 (HER2- ...and HER2 on their cell ...and HER2 positive tumor ...A. HER2 enriched (HR- /HER2+) breast cancers have HER2 over expressing tumor ...on HER2 ...
143
Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes
... The veracity of our findings is supported by the fact that clinical trials are currently underway to test the efficacy of novel inhibitors to limit disease progression. A new FASN inhibitor, TVB-2640, is currently being ...
9
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives
... node-negative, HER2-negative patients with a low Oncotype DX RS (#10) receiving endocrine therapy alone (n = 1,626) resulted in a 5-year invasive disease-free survival and distant recurrence-free survival rates of ...
10
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
... Development of metastatic disease is a highly selective proc- ess. Only a small portion of tumor cells of the primary tumor have the ability to initiate metastatic growth at a different organ site. Additional genetic ...
8
Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
... on HER2 status determined by immunohistochemistry as documented in medical ...with HER2-positive status (score 3 + ) and 17 patients with HER2-negative status (scores 0 and 1 + ...
5
Intra tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
... with HER2 amplification in the TCGA luminal breast cancer dataset (Figure 3B) ...DSN1 overexpression led to larger, multiacinar structures with filled lumens (Figure 4D), in line with phenotypes previously ...
21